News

Researchers also identified 50% improvement in appearance with larger spot laser use.

Click here to answer this week's poll.

The current dermatology pipeline includes a wide range of medication classes, from Janus kinase (JAK) inhibitors to tumor necrosis factor inhibitors, to phototherapeutics

The new technique analyzes RNA from infant sebum samples.

Jennifer Orozco, DMSc, PA-C, DFAAPA, oversees the American Academy of Physician Associates and advocates for the role of PAs.

More than $600,000 have been donated to raise awareness of melanoma with the #Stickit2Melanoma pledge.

If you weren’t able to attend Fall Clinical for PAs and NPs or want to review our latest coverage and interviews, our full recap has you covered.

Joan Merrill, MD, explained the study's efficacy and safety outcomes and looks forward to phase 3 trials ahead.

Despite this, researchers found that Hsp70 plasma levels did not correlate with the extent of disease.

Level Ex, Inc.'s Top Derm is changing the way dermatologists learn about skin conditions—all through a cell phone screen.

A poster presentation from the Fall Clinical Dermatology Conference for PAs and NPs evaluated the safety and efficacy of tazarotene for acne patients with skin of color.

In this episode, Jonathan Silverberg, MD, PhD, MPH, discusses of the effects of environmental pollutants on atopic dermatitis, including flares, severity, and recommendations for avoiding these pollutants when possible.

Roger Ceilley, MD, reviewed his best tips for ensuring the best patient outcomes after surgical procedures at the 2023 Fall Clinical Dermatology Conference for PAs and NPs.

Catch up on coverage from the final day of the 2023 Fall Clinical Dermatology Conference for PAs and NPs.

Cameron guided attendees at the Fall Clinical Dermatology Conference for PAs and NPs on his treatment considerations for psoriasis and pigmentary disorders during his 2 sessions.

Zeichner reviewed his top 3 acne treatment pearls at the Fall Clinical Dermatology Conference for PAs and NPs.

Stein Gold reviewed biologics and JAK inhibitors for AD at Fall Clinical for PAs and NPs, as well as topical and oral agents for tough acne.

Reynolds discussed what attendees need to know about using cemiplimab to target their difficult skin cancer patients at the Fall Clinical Dermatology Conference for PAs and NPs.

Catch up on coverage from the second day of the 2023 Fall Clinical Dermatology Conference for PAs and NPs.

Givens presented tips for all dermatology providers to consider at the 2023 Fall Clinical Dermatology Conference for PAs and NPs.

Adelaide Hebert, MD, reviewed ichthyosis, epidermolysis bullosa, molluscum contagiosum, and more at the 2023 Fall Clinical Dermatology Conference for PAs and NPs.

Bunick spoke at the Fall Clinical Dermatology Conference for PAs and NPs to discuss important considerations of biologics use for atopic dermatitis management.

Neal Bhatia, MD, will guide attendees at Fall Clinical PA & NP on the difference between JAKs and TYKs, as well as the role of PAs and NPs in clinical research.

Among the many sessions to be held at the 2023 Fall Clinical Dermatology Conference for PAs & NPs in Orlando, Florida, several Dermatology Times® Editorial Advisory Board members are preparing to share their knowledge and insights.

Catch up on coverage from the first day of the 2023 Fall Clinical Dermatology Conference for PAs and NPs.

Investigators compared data among patients with vitiligo and the general population.

The majority of patients with moderate-to-severe SD have a negatively impacted quality of life, according to a poster presentation from Fall Clinical for PAs and NPs.

Miller is presenting 3 sessions at the 2023 Fall Clinical Dermatology Conference for PAs and NPs.

No matter where you go, there is something for everyone to enjoy in Orlando after sessions have ended for the day at Fall Clinical for PAs and NPs.

The benefits include more accurate bacteria cell counts, more efficacious strains, and improved shelf life compared to non-heat-treated probiotics.